Pavan Vaddady

9PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsStochastic analysis and modellingModelling and simulationMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 11, 2025
Exposure-Response Relationships in Patients with Non-Small-Cell Lung Cancer and Other Solid Tumors Treated with Patritumab Deruxtecan (HER3-DXd).

Li Li, Mark Lee, Rujuta Joshi

|Nov 27, 2024
Population pharmacokinetic analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia.

Pavan Vaddady, Anaïs Glatard, Giovanni Smania

|Nov 13, 2024
Concentration-QTcF analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia.

Pavan Vaddady, Giovanni Smania, Shintaro Nakayama

|Oct 28, 2024
Within-chain parallelization-Giving Stan Jet Fuel for population modeling in pharmacometrics.

Casey Davis, Pavan Vaddady

|May 16, 2024
Dose Optimization in Oncology Drug Development: An International Consortium for Innovation and Quality in Pharmaceutical Development White Paper.

Divya Samineni, Karthik Venkatakrishnan, Ahmed A Othman

|Nov 02, 2023
Application of the model-informed drug development paradigm to datopotamab deruxtecan dose selection for late-stage development.

Yasong Lu, Shuang Liang, Ying Hong

Pageof 2

Frequent Collaborators

2 joint publications

Abhinav Kurumaddali

1 joint publications

Moises Hernandez

1 joint publications

Marcus Hompesch

1 joint publications

Linda Morrow